Chemische Fabrik Kreussler & CO GmbH   Report issue

Contributed to NME For profit Phase 4
Founded: Wiesbaden Germany (1912)

Organization Overview

First Clinical Trial
2017
NCT03354312
First Marketed Drug
2010
polidocanol (asclera)
First NDA Approval
2010
polidocanol (asclera)
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

CHEMISCHE FABRIK KREUSSLER & CO. | Chemische Fabrik Kreussler & CO GmbH | CHEMISCH FBRK KRSSLR